Global Precision Cancer Tests Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Precision Cancer Tests Market Overview

• 1.1 Product Overview and Scope of Precision Cancer Tests
• 1.2 Classification of Precision Cancer Tests by Types
  • 1.2.1 Global Precision Cancer Tests Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Precision Cancer Tests Revenue Market Share by Types in 2018
  • 1.2.3 Imaging
  • 1.2.4 In Vitro Diagnostic
  • 1.2.5 Others
• 1.3 Global Precision Cancer Tests Market by Application
  • 1.3.1 Global Precision Cancer Tests Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Cancer Research Centers
  • 1.3.3 Cancer Hospital
  • 1.3.4 Surgical Centers
  • 1.3.5 Clinics
  • 1.3.6 Others
• 1.4 Global Precision Cancer Tests Market by Regions
  • 1.4.1 Global Precision Cancer Tests Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Precision Cancer Tests Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Precision Cancer Tests Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Precision Cancer Tests Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Precision Cancer Tests Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Precision Cancer Tests Status and Prospect (2014-2024)
• 1.5 Global Market Size of Precision Cancer Tests (2014-2024)

2 Manufacturers Profiles

• 2.1 Abbott
  • 2.1.1 Business Overview
  • 2.1.2 Precision Cancer Tests Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Abbott Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 BD
  • 2.2.1 Business Overview
  • 2.2.2 Precision Cancer Tests Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 BD Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Bio-Rad
  • 2.3.1 Business Overview
  • 2.3.2 Precision Cancer Tests Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Bio-Rad Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Cynvenio Biosystems
  • 2.4.1 Business Overview
  • 2.4.2 Precision Cancer Tests Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Cynvenio Biosystems Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Foundation Medicine
  • 2.5.1 Business Overview
  • 2.5.2 Precision Cancer Tests Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Foundation Medicine Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Genomic Health
  • 2.6.1 Business Overview
  • 2.6.2 Precision Cancer Tests Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Genomic Health Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Illumina
  • 2.7.1 Business Overview
  • 2.7.2 Precision Cancer Tests Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Illumina Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Myriad Genetics
  • 2.8.1 Business Overview
  • 2.8.2 Precision Cancer Tests Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Myriad Genetics Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 NanoString Technologies
  • 2.9.1 Business Overview
  • 2.9.2 Precision Cancer Tests Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 NanoString Technologies Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 QIAGEN
  • 2.10.1 Business Overview
  • 2.10.2 Precision Cancer Tests Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 QIAGEN Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Randox Laboratories
  • 2.11.1 Business Overview
  • 2.11.2 Precision Cancer Tests Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Randox Laboratories Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Roche
  • 2.12.1 Business Overview
  • 2.12.2 Precision Cancer Tests Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Roche Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Philips
  • 2.13.1 Business Overview
  • 2.13.2 Precision Cancer Tests Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Philips Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Thermo Fisher Scientific
  • 2.14.1 Business Overview
  • 2.14.2 Precision Cancer Tests Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Thermo Fisher Scientific Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2018)

3 Global Precision Cancer Tests Market Competition, by Players

• 3.1 Global Precision Cancer Tests Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Precision Cancer Tests Players Market Share
  • 3.2.2 Top 10 Precision Cancer Tests Players Market Share
• 3.3 Market Competition Trend

4 Global Precision Cancer Tests Market Size by Regions

• 4.1 Global Precision Cancer Tests Revenue and Market Share by Regions
• 4.2 North America Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 4.3 Europe Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 4.5 South America Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Precision Cancer Tests Revenue and Growth Rate (2014-2019)

5 North America Precision Cancer Tests Revenue by Countries

• 5.1 North America Precision Cancer Tests Revenue by Countries (2014-2019)
• 5.2 USA Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 5.3 Canada Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Precision Cancer Tests Revenue and Growth Rate (2014-2019)

6 Europe Precision Cancer Tests Revenue by Countries

• 6.1 Europe Precision Cancer Tests Revenue by Countries (2014-2019)
• 6.2 Germany Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 6.3 UK Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 6.4 France Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 6.5 Russia Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 6.6 Italy Precision Cancer Tests Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Precision Cancer Tests Revenue by Countries

• 7.1 Asia-Pacific Precision Cancer Tests Revenue by Countries (2014-2019)
• 7.2 China Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 7.3 Japan Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 7.4 Korea Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 7.5 India Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Precision Cancer Tests Revenue and Growth Rate (2014-2019)

8 South America Precision Cancer Tests Revenue by Countries

• 8.1 South America Precision Cancer Tests Revenue by Countries (2014-2019)
• 8.2 Brazil Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Precision Cancer Tests Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Precision Cancer Tests by Countries

• 9.1 Middle East and Africa Precision Cancer Tests Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 9.3 UAE Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Precision Cancer Tests Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Precision Cancer Tests Revenue and Growth Rate (2014-2019)

10 Global Precision Cancer Tests Market Segment by Type

• 10.1 Global Precision Cancer Tests Revenue and Market Share by Type (2014-2019)
• 10.2 Global Precision Cancer Tests Market Forecast by Type (2019-2024)
• 10.3 Imaging Revenue Growth Rate (2014-2024)
• 10.4 In Vitro Diagnostic Revenue Growth Rate (2014-2024)
• 10.5 Others Revenue Growth Rate (2014-2024)

11 Global Precision Cancer Tests Market Segment by Application

• 11.1 Global Precision Cancer Tests Revenue Market Share by Application (2014-2019)
• 11.2 Precision Cancer Tests Market Forecast by Application (2019-2024)
• 11.3 Cancer Research Centers Revenue Growth (2014-2019)
• 11.4 Cancer Hospital Revenue Growth (2014-2019)
• 11.5 Surgical Centers Revenue Growth (2014-2019)
• 11.6 Clinics Revenue Growth (2014-2019)
• 11.7 Others Revenue Growth (2014-2019)

12 Global Precision Cancer Tests Market Size Forecast (2019-2024)

• 12.1 Global Precision Cancer Tests Market Size Forecast (2019-2024)
• 12.2 Global Precision Cancer Tests Market Forecast by Regions (2019-2024)
• 12.3 North America Precision Cancer Tests Revenue Market Forecast (2019-2024)
• 12.4 Europe Precision Cancer Tests Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Precision Cancer Tests Revenue Market Forecast (2019-2024)
• 12.6 South America Precision Cancer Tests Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Precision Cancer Tests Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology